[HTML][HTML] Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France
K Bowrin, JB Briere, L Fauchier, C Coleman, A Millier… - PLoS …, 2020 - journals.plos.org
… effectiveness (VKA rates and comparative effectiveness). A previous … 18 cost-effectiveness
models comparing rivaroxaban and other NOACs with VKAs for stroke prevention in patients …
models comparing rivaroxaban and other NOACs with VKAs for stroke prevention in patients …
[HTML][HTML] Apixaban versus other anticoagulants in patients with nonvalvular fibrillation: a comparison of all-cause and event-related costs in real-life setting in France
M Belhassen, O Hanon, PG Steg, I Mahé… - The European Journal of …, 2023 - Springer
… safety than rivaroxaban, similar safety to dabigatran, and similar effectiveness than rivaroxaban
in patients initiating oral anticoagulant (… In France, cost-effectiveness studies have shown …
in patients initiating oral anticoagulant (… In France, cost-effectiveness studies have shown …
Cost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patients
E Walter, M Voit, G Eichhober - Expert Review of …, 2021 - Taylor & Francis
… with NVAF in the ARISTOTLE study [Citation10] and versus aspirin … cost-effectiveness
analyses of apixaban in comparison with other DOACs (apixaban, dabigatran 110mg, dabigatran …
analyses of apixaban in comparison with other DOACs (apixaban, dabigatran 110mg, dabigatran …
Real-world cost-effectiveness of rivaroxaban and apixaban vs VKA in stroke prevention in non-valvular atrial fibrillation in the UK
K Bowrin, JB Briere, P Levy, A Millier, J Tardu… - Journal of Market …, 2020 - mdpi.com
… context of stroke prevention in atrial fibrillation in France. PLoS … of stroke and stroke prophylaxis
with aspirin or warfarin on … cost-effectiveness analyses of novel oral anticoagulants for …
with aspirin or warfarin on … cost-effectiveness analyses of novel oral anticoagulants for …
[HTML][HTML] Oral anticoagulants for stroke prevention in atrial fibrillation: a systematic review of economic evaluations
… are doubts about the cost-effectiveness of new oral anticoagulants. … warfarin with 3
comparative arms of apixaban, dabigatran, and rivaroxaban, 4% of the studies with 2 comparative …
comparative arms of apixaban, dabigatran, and rivaroxaban, 4% of the studies with 2 comparative …
Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
AS Hersi, KM Osenenko, SA Kherraf… - Annals of Saudi …, 2019 - annsaudimed.net
… that oral anticoagulation therapy be used for stroke prevention … to other anticoagulant therapies,
aspirin and aspirin plus … impact on the cost-effectiveness of apixaban relative to the other …
aspirin and aspirin plus … impact on the cost-effectiveness of apixaban relative to the other …
Cost-Effectiveness analysis of direct-acting oral anticoagulants for stroke prevention in Thai patients with Non-Valvular atrial fibrillation and a high risk of bleeding
T Rattanachotphanit, C Limwattananon… - …, 2019 - Springer
… oral anticoagulants (DOACs), including apixaban, dabigatran… , anticoagulants were
discontinued and replaced with aspirin… performed by comparing an outcome of patient survival in …
discontinued and replaced with aspirin… performed by comparing an outcome of patient survival in …
[HTML][HTML] Cost-effectiveness analysis of direct oral anticoagulants vs. vitamin K antagonists in the elderly with atrial fibrillation: insights from the evidence in a real-world …
Y Wu, C Zhang, ZC Gu - Frontiers in Cardiovascular Medicine, 2021 - frontiersin.org
… estimate and compare the cost-effectiveness of DOACs (dabigatran, rivaroxaban, apixaban,
… were assumed to discontinue the therapy of anticoagulants and switch to aspirin in case of …
… were assumed to discontinue the therapy of anticoagulants and switch to aspirin in case of …
Cost-effectiveness analysis of pharmacogenomics (PGx)-based warfarin, apixaban, and rivaroxaban versus standard warfarin for the management of atrial fibrillation …
… , and rivaroxaban relative to standard warfarin for patients with … aspirin therapy, these
patients resumed oral anticoagulant … , dabigatran was not considered as an oral anticoagulant …
patients resumed oral anticoagulant … , dabigatran was not considered as an oral anticoagulant …
Cost-effectiveness of warfarin care bundles and novel oral anticoagulants for stroke prevention in patients with atrial fibrillation in Thailand
SS Ng, S Nathisuwan, A Phrommintikul… - Thrombosis research, 2020 - Elsevier
… (Watchman device), dabigatran 150 mg, rivaroxaban 20 mg, apixaban 5 mg and edoxaban
… it is the first published economic evaluation comparing warfarin care bundles and NOACs …
… it is the first published economic evaluation comparing warfarin care bundles and NOACs …